BTIG Reiterates Buy Rating on BrightSpring Health Services, Inc.
BTIG reaffirms its buy rating for BrightSpring Health Services, Inc. with a $90 price target, a 33.12% upside from the current price.
Key Points
- BTIG reiterated its buy rating for BrightSpring Health Services, Inc. (BTSG) on June 22, 2026, with a price target of $90.
- BTIG's $90 price target implies 33.12% upside from BrightSpring Health Services, Inc.'s ($BTSG) current $67.61 share price.
- Shares of BTSG traded at $66.25 on Monday, with a market cap of $13 billion and a forward P/E of 31.3.
- Insider transactions included sales by executives and a recent buy by Shah Nigam, while analysts remain positive with multiple buy ratings.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
BTIG has reiterated its buy rating for BrightSpring Health Services, Inc. (NasdaqGS: BTSG) with a price target of $90. This reaffirmation came on June 22, 2026, as analyst David Larsen expressed continued confidence in the company's prospects.
BTIG vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
BrightSpring Health Services, Inc. Stock Up 14.3%
Shares of NasdaqGS:BTSG traded near $66.25 on Monday. BrightSpring Health Services, Inc. boasts a market cap of approximately $13 billion and a forward P/E ratio of 31.3. The stock's 52-week range spans from $19.01 to $66.69, with a 50-day moving average of $54.90 and a 200-day moving average of $40.52. The company maintains a current ratio of 1.737 and a quick ratio of 1.356, with a debt-to-equity ratio of 135.679, indicating a moderate level of leverage.
$BTSG price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
BrightSpring Health Services reported revenue of $13.65 billion, reflecting a growth rate of 25.6%. The company achieved a net margin of 2.27% and a return on equity of 9.23%. With an EPS of $0.77, the next earnings report is anticipated on July 31, 2026.
Insider Buying and Selling at BrightSpring Health Services, Inc.
Recent insider transactions at BrightSpring Health Services include a purchase by Shah Nigam of 4,013 shares on June 11, 2026. On June 5, 2026, Chairman, President, and CEO Jon Rousseau sold 260,000 shares. Additionally, Chief of Staff and Senior Vice President, Human Resources, Lisa Nalley, sold 35,000 shares at an average price of $58.75, while also buying 35,000 shares at $6.37.
Analysts Set New Price Targets
On June 22, 2026, BTIG maintained its buy rating with a $90 price target. This follows TD Cowen's buy rating with an $81 target on June 18, and Goldman Sachs initiating a buy rating at $71 on June 8. Morgan Stanley also maintained a buy rating with a $71 target on June 2. The consensus among 16 analysts is a strong buy, with an average target price of $64.75.
About BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc., headquartered in Louisville, Kentucky, operates as a home and community-based healthcare services platform across the United States. The company focuses on delivering pharmacy and provider services within home and community settings, catering to Medicare, Medicaid, and insured populations. BrightSpring offers a range of services, including clinical care, rehabilitation, and medication management, under the leadership of CEO Jon B. Rousseau. Founded in 1974, the company employs around 23,500 people.
Bottom Line
BTIG's reaffirmation of its buy rating and $90 price target reflects continued optimism for BrightSpring Health Services, Inc. Investors closely monitor such analyst ratings and insider transactions to gauge company performance. As a reminder, 13F filings and analyst ratings provide a snapshot of past positions and opinions, which may not reflect the current market view.
Get BrightSpring Health Services, Inc. alerts
New 13F filings, insider trades, and analyst moves on $BTSG, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.